Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Autoimmune Disease Diagnosis Market Poised To Hit $9.38 Billion By 2030 With A 8.6% CAGR
The autoimmune disease diagnosis market size has experienced substantial growth in recent years. It is projected to increase from $6.2 billion in 2025 to $6.74 billion in 2026, progressing at a compound annual growth rate (CAGR) of 8.8%. This growth observed in the past can be attributed to the rising prevalence of autoimmune diseases, enhanced availability of immunoassay technologies, the expansion of clinical laboratory networks, increased physician awareness of autoimmune conditions, and the broader adoption of routine screening tests.
The autoimmune disease diagnosis market size is projected to experience robust expansion over the coming years. This market is forecast to reach $9.38 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.6%. This anticipated growth during the forecast period is driven by factors such as a heightened demand for prompt and precise diagnosis, the growing application of AI-assisted diagnostic analytics, the spread of personalized diagnostic methods, increased funding in autoimmune research, and the greater incorporation of point-of-care testing. Key trends expected within this period encompass the wider adoption of sophisticated immunological testing, an uptick in the utilization of autoantibody panels, the increasing incorporation of multiplex diagnostic platforms, the expansion of laboratory automation, and a sharpened emphasis on identifying diseases early.
Get A Free Sample Report With In-Depth Market Insights:
Autoimmune Disease Diagnosis Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The growing occurrence of autoimmune diseases has fueled the expansion of the autoimmune disease diagnosis market. Autoimmune diseases are conditions where the body’s immune system incorrectly attacks its own healthy cells, tissues, or organs. The increase in these diseases stems from heightened exposure to environmental triggers such as pollution and infections, as well as lifestyle changes that can disrupt immune regulation. Autoimmune disease diagnosis serves to accurately pinpoint the specific immune disorder, allowing for timely and appropriate treatment to commence and better management of disease progression. For instance, in March 2023, according to Society for Women’s Health Research, a U.S-based non-profit organisation, it was reported that autoimmune diseases are estimated to affect 23.5 million to 50 million individuals. Moreover, the global rates of autoimmune diseases are escalating by between 3-9 percent each year. Therefore, the rising global incidence of autoimmune diseases is a primary driver for the growth of the autoimmune disease diagnosis market.
Autoimmune Disease Diagnosis Market Segment Landscape: Which Areas Lead Development?
The autoimmune disease diagnosis market covered in this report is segmented –
1) By Product: Consumables And Assay Kits, Instruments
2) By Test Type: Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests
3) By End User: Clinical Laboratories, Hospitals, Other End Users
Subsegments:
1) By Consumables And Assay Kits: ELISA Kits, Reagents And Test Kits, Sample Collection And Preservation Devices, Control And Calibration Materials
2) By Instruments: Immunoassay Analyzers, Flow Cytometers, Luminometers, Microscopes
Autoimmune Disease Diagnosis Market Innovation Trends Shaping Future Development
Leading firms within the autoimmune disease diagnosis market are concentrating on creating technological innovations, particularly multiplex autoantibody assay platforms, to achieve thorough, prompt, and accurate identification of autoimmune conditions, thereby enhancing diagnostic precision and patient care. Such a platform facilitates the concurrent identification of numerous disease-specific autoantibodies from a sole patient specimen, which boosts sensitivity and specificity when contrasted with conventional single-analyte ELISA or immunofluorescence tests, alongside minimizing required sample volume and processing duration. Illustratively, in January 2025, Exagen Inc., a diagnostics company based in the U.S., introduced its AVISE CTD platform, which incorporates novel biomarker assays for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). This platform identifies innovative biomarkers including TIgG, TIgM, and TC4d, empowering clinicians to differentiate between overlapping autoimmune conditions with greater precision and simplify patient diagnosis, all while integrating smoothly into current testing protocols.
Autoimmune Disease Diagnosis Market Industry Leaders And Competitive Landscape
Major companies operating in the autoimmune disease diagnosis market are Siemens Healthineers AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Danaher Corporation, AESKU Diagnostics GmbH & Co. KG, Trinity Biotech plc, bioMérieux SA, SQI Diagnostics, Philips Healthcare India, Agappe Diagnostics Ltd, Lepu Medical Technology Company (Beijing) Co., Ltd, Shanghai Runda Medical Technology Co., Ltd, GE Healthcare China Co., Ltd, Roche Holding AG, Koninklijke Philips, Theradiag, Becton Dickinson and Company, Ortho Clinical Diagnostics
View The Full Autoimmune Disease Diagnosis Market Report:
Autoimmune Disease Diagnosis Market Regional Analysis: Which Geography Leads On Revenue?
North America was the largest region in the autoimmune disease diagnosis market in 2025. Western Europe was the second largest region in the autoimmune disease diagnosis market share. The regions covered in the autoimmune disease diagnosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.